Valérie Bouchez, Julie Toubiana, Sophie Guillot, Parapertussis Study Group, Fatima Aït El Belghiti, Annie Landier, Nathalie Armatys, Sabine Trombert-Paolantoni, Anaïs Soares, Carla Rodrigues, Sylvain Brisse
{"title":"Transient reemergence of <i>Bordetella parapertussis</i> in France in 2022.","authors":"Valérie Bouchez, Julie Toubiana, Sophie Guillot, Parapertussis Study Group, Fatima Aït El Belghiti, Annie Landier, Nathalie Armatys, Sabine Trombert-Paolantoni, Anaïs Soares, Carla Rodrigues, Sylvain Brisse","doi":"10.1099/jmm.0.001843","DOIUrl":null,"url":null,"abstract":"<p><p>Between March and October 2022, a peak of detection of <i>Bordetella parapertussis</i> by qPCR, real-time PCR was observed in France.<b>Hypothesis/Gap Statement.</b> Whether this peak was due to resurgence from previous circulating lineages or reintroduction into the country was unknown.<b>Objective.</b> The objective of this study is to understand <i>B. parapertussis-</i>transient increase observed in France in 2022 whereas it had virtually stopped being reported since the start of the COVID-19 pandemic in 2020.<b>Methods.</b> We analysed real-time PCR (qPCR) data from the two largest French outpatient laboratories performing whooping cough diagnosis and characterized all <i>B. parapertussis</i> isolates collected in the 2016-2022 period by the French National Reference Centre for Whooping Cough.<b>Results.</b> Microbiological analyses reveal that 13 of 18 bacterial isolates collected in 2022 produce the vaccine antigen pertactin, whereas none of the 22 isolates collected in the 2016-2021 period did.<b>Conclusion.</b> We hypothesize a re-introduction of <i>B. parapertussis</i> from regions of the world where whole-cell vaccines are still in use.</p>","PeriodicalId":94093,"journal":{"name":"Journal of medical microbiology","volume":"73 7","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of medical microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1099/jmm.0.001843","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Between March and October 2022, a peak of detection of Bordetella parapertussis by qPCR, real-time PCR was observed in France.Hypothesis/Gap Statement. Whether this peak was due to resurgence from previous circulating lineages or reintroduction into the country was unknown.Objective. The objective of this study is to understand B. parapertussis-transient increase observed in France in 2022 whereas it had virtually stopped being reported since the start of the COVID-19 pandemic in 2020.Methods. We analysed real-time PCR (qPCR) data from the two largest French outpatient laboratories performing whooping cough diagnosis and characterized all B. parapertussis isolates collected in the 2016-2022 period by the French National Reference Centre for Whooping Cough.Results. Microbiological analyses reveal that 13 of 18 bacterial isolates collected in 2022 produce the vaccine antigen pertactin, whereas none of the 22 isolates collected in the 2016-2021 period did.Conclusion. We hypothesize a re-introduction of B. parapertussis from regions of the world where whole-cell vaccines are still in use.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
